PT2922551T - Novos compostos como inibidores de diacilglicerol aciltransferase - Google Patents

Novos compostos como inibidores de diacilglicerol aciltransferase

Info

Publication number
PT2922551T
PT2922551T PT13856479T PT13856479T PT2922551T PT 2922551 T PT2922551 T PT 2922551T PT 13856479 T PT13856479 T PT 13856479T PT 13856479 T PT13856479 T PT 13856479T PT 2922551 T PT2922551 T PT 2922551T
Authority
PT
Portugal
Prior art keywords
new compounds
diacylglycerol acyltransferase
acyltransferase inhibitors
inhibitors
diacylglycerol
Prior art date
Application number
PT13856479T
Other languages
English (en)
Portuguese (pt)
Inventor
Cheung Mui
S Tangirala Raghuram
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of PT2922551T publication Critical patent/PT2922551T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Child & Adolescent Psychology (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT13856479T 2012-11-23 2013-11-22 Novos compostos como inibidores de diacilglicerol aciltransferase PT2922551T (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3593DE2012 2012-11-23
IN750DE2013 2013-03-14
IN3172DE2013 2013-10-25

Publications (1)

Publication Number Publication Date
PT2922551T true PT2922551T (pt) 2019-02-04

Family

ID=50776577

Family Applications (1)

Application Number Title Priority Date Filing Date
PT13856479T PT2922551T (pt) 2012-11-23 2013-11-22 Novos compostos como inibidores de diacilglicerol aciltransferase

Country Status (31)

Country Link
US (1) US20150322082A1 (enExample)
EP (2) EP3492474B1 (enExample)
JP (1) JP6279600B2 (enExample)
KR (1) KR102176463B1 (enExample)
CN (1) CN104918620B (enExample)
AU (1) AU2013347843B2 (enExample)
BR (1) BR112015011982A8 (enExample)
CA (1) CA2892304C (enExample)
CL (1) CL2015001397A1 (enExample)
CY (1) CY1121426T1 (enExample)
DK (1) DK2922551T3 (enExample)
EA (1) EA031114B1 (enExample)
ES (1) ES2708626T3 (enExample)
HR (1) HRP20190099T1 (enExample)
HU (1) HUE042483T2 (enExample)
IL (1) IL238835B (enExample)
LT (1) LT2922551T (enExample)
ME (1) ME03315B (enExample)
MX (1) MX363484B (enExample)
NZ (1) NZ630436A (enExample)
PE (1) PE20150967A1 (enExample)
PH (1) PH12015501109A1 (enExample)
PL (1) PL2922551T3 (enExample)
PT (1) PT2922551T (enExample)
RS (1) RS58539B1 (enExample)
SG (1) SG11201503761WA (enExample)
SI (1) SI2922551T1 (enExample)
SM (1) SMT201900230T1 (enExample)
UA (1) UA115079C2 (enExample)
WO (1) WO2014081994A1 (enExample)
ZA (1) ZA201503304B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018052818A (ja) * 2015-01-28 2018-04-05 武田薬品工業株式会社 スルホンアミド化合物
CN109963561A (zh) * 2016-11-18 2019-07-02 默沙东公司 可用作二酰基甘油酯o-酰基转移酶2的抑制剂的吲哚衍生物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100795462B1 (ko) * 2006-09-27 2008-01-16 한국생명공학연구원 인돌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 대사성 질환 예방 및 치료용 약학적 조성물
US20090036425A1 (en) * 2007-08-02 2009-02-05 Pfizer Inc Substituted bicyclolactam compounds
US20090076275A1 (en) * 2007-09-19 2009-03-19 David Robert Bolin Diacylglycerol acyltransferase inhibitors
AR066169A1 (es) * 2007-09-28 2009-07-29 Novartis Ag Derivados de benzo-imidazoles, utiles para trastornos asociados con la actividad de dgat
US8324385B2 (en) * 2008-10-30 2012-12-04 Madrigal Pharmaceuticals, Inc. Diacylglycerol acyltransferase inhibitors
TW201038580A (en) 2009-02-02 2010-11-01 Pfizer 4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl derivatives
WO2011121350A1 (en) 2010-04-01 2011-10-06 Astrazeneca Ab 4 -amino -7,8- dihydropyrimido [5, 4 - f] [1, 4] oxazepin- 5 ( 6h) - one based dgat1 inhibitors
KR101919080B1 (ko) * 2011-05-20 2018-11-16 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 디아실글리세롤 아실트랜스퍼라제 억제제로서의 신규 화합물

Also Published As

Publication number Publication date
EP3492474A1 (en) 2019-06-05
EP2922551B1 (en) 2018-10-31
LT2922551T (lt) 2019-02-11
CN104918620A (zh) 2015-09-16
DK2922551T3 (en) 2019-02-18
HK1214757A1 (en) 2016-08-05
IL238835B (en) 2019-07-31
CA2892304C (en) 2021-03-30
EP2922551A1 (en) 2015-09-30
IL238835A0 (en) 2015-06-30
ME03315B (me) 2019-10-20
ZA201503304B (en) 2016-05-25
SG11201503761WA (en) 2015-06-29
JP2016500109A (ja) 2016-01-07
US20150322082A1 (en) 2015-11-12
BR112015011982A2 (pt) 2017-07-11
JP6279600B2 (ja) 2018-02-14
HUE042483T2 (hu) 2019-06-28
SI2922551T1 (sl) 2019-05-31
CL2015001397A1 (es) 2015-08-28
KR102176463B1 (ko) 2020-11-09
CN104918620B (zh) 2017-06-09
MX363484B (es) 2019-03-21
ES2708626T3 (es) 2019-04-10
EP2922551A4 (en) 2016-04-27
KR20150087852A (ko) 2015-07-30
SMT201900230T1 (it) 2019-07-11
AU2013347843B2 (en) 2016-06-16
WO2014081994A1 (en) 2014-05-30
PH12015501109B1 (en) 2015-08-17
MX2015006533A (es) 2015-08-06
PH12015501109A1 (en) 2015-08-17
HRP20190099T1 (hr) 2019-04-19
AU2013347843A1 (en) 2015-05-28
NZ630436A (en) 2016-08-26
PE20150967A1 (es) 2015-06-25
UA115079C2 (uk) 2017-09-11
EA031114B1 (ru) 2018-11-30
BR112015011982A8 (pt) 2019-10-08
CY1121426T1 (el) 2020-05-29
PL2922551T3 (pl) 2019-06-28
EA201590982A1 (ru) 2015-11-30
CA2892304A1 (en) 2014-05-30
EP3492474B1 (en) 2021-08-11
RS58539B1 (sr) 2019-04-30

Similar Documents

Publication Publication Date Title
CO6811855A2 (es) Compuestos novedosos como inhibidores de diacilglicerol aciltransferasa
PT3459942T (pt) Inibidores de adn-pk
CO7010838A2 (es) Compuestos de imidazopirrolidinona
CO7061086A2 (es) Combinaciones de compuestos activos
CO6880068A2 (es) Aminoquinazolinas como inhibidores de quinasa
CO6920291A2 (es) 3-pirmidin-4-il-oxazolidin-2-onas como inhibidores de la idhmutante
PT3068786T (pt) Compostos de pirazolopirimidina
BR112013015449A2 (pt) compostos de bi-heteroarila como inibidores de vps23
IL234928A0 (en) Inhibitors of diacylglycerol acyltransferase 2 and their uses
BR112014023606A2 (pt) Bandeja de testemunho
CO6862145A2 (es) Imidazopiridazinas como inhibidores de quinasa akt
IL239447A0 (en) Novel compounds
DK2804611T3 (da) Chitosanafledte forbindelser
EP2911563A4 (en) DONOR
EP2858975A4 (en) FBXO3 INHIBITORS
FR2987600B1 (fr) Nacelle aplatie de turboreacteur
CO6811853A2 (es) Compuestos novedosos como inhibidores de diacilglicerol aciltransferasa
BR112013005210A2 (pt) compostos heterocíclicos como inibidores de dgat1
HUE042483T2 (hu) Diacilglicerin-aciltranszferáz-gátló új vegyületek
BR112013029805A2 (pt) novos compostos como inibidores de diacilglicerol aciltransferase
FR2997080B1 (fr) Inhibiteurs de neprilysine
ES2390324B8 (es) Juego de brocas
TH1301007216B (th) สารประกอบโครมีน